CR MEDICAL (01515) · Company profile · Eqvero

CR MEDICAL

01515HKEX

Unit: CNY	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	9.18 bn CNY	9.85 bn CNY	10.11 bn CNY	5.62 bn CNY	4.45 bn CNY
Cost of revenue	7.15 bn CNY	7.43 bn CNY	7.59 bn CNY	4.32 bn CNY	3.33 bn CNY
Selling, general and administrative expense	995.87 m CNY	1.05 bn CNY	973.5 m CNY	648.28 m CNY	488.23 m CNY
Operating profit after depreciation	422.51 m CNY	753.21 m CNY	852.24 m CNY	284.64 m CNY	367.68 m CNY
Operating profit before depreciation	1.01 bn CNY	1.37 bn CNY	1.46 bn CNY	617.13 m CNY	550.56 m CNY
EBIT	422.51 m CNY	753.21 m CNY	852.24 m CNY	284.64 m CNY	367.68 m CNY
EBITDA	1.01 bn CNY	1.37 bn CNY	1.46 bn CNY	617.13 m CNY	550.56 m CNY
Interest expense	31.95 m CNY	61.01 m CNY	114.86 m CNY	46.23 m CNY	16.23 m CNY
Profit before tax	747.67 m CNY	838.67 m CNY	492.92 m CNY	242.41 m CNY	270.48 m CNY
Income tax expense	191.57 m CNY	166.92 m CNY	165.03 m CNY	83.07 m CNY	-155.39 m CNY
Income before extraordinary items	495.94 m CNY	565.88 m CNY	257.68 m CNY	138.97 m CNY	417.92 m CNY
Common dividends	173.76 m CNY	171.16 m CNY	77.8 m CNY	42.44 m CNY	126.76 m CNY
Total dividends	173.76 m CNY	171.16 m CNY	77.8 m CNY	42.44 m CNY	126.76 m CNY

Quotes are end-of-day data. Content is for research purposes and is not investment advice.